DFine rakes in $30m for spine surgical tech
This article was originally published in Clinica
San Jose, California-based orthopaedic company DFine has secured $30m in series D financing, which it will use to expand commercialisation of its minimally-invasive spinal surgery technology. The financing was led by BBT Fund and Highland Capital Management. The company's StabiliT vertebral augmentation system is designed to treat vertebral compression fractions caused by osteoporosis or cancer. The system injects a bone cement, made from a proprietary energy-responsive polymethymethacrylate (PMMA) formulation, into the fractured vertebral column to stabilise the spine. The StabiliT is able to increase the viscosity of the cement by applying energy to the material. The system is commercially available in the US, and can be used only for clinical investigation in Europe.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.